MYELODYSPLASTIC SYNDROMES
Clinical trials for MYELODYSPLASTIC SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could patients stop anti-rejection drugs sooner after transplant?
Disease control Not yet recruitingThis study tests whether it is safe to stop the anti-rejection drug tacrolimus early after a stem cell transplant. About 50 people with blood cancers or bone marrow disorders will receive a modern GVHD prevention method and then stop tacrolimus by day 88. The goal is to see if th…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 01, 2026 15:25 UTC
-
New hope for High-Risk leukemia: interferon drug may keep cancer away after transplant
Disease control Not yet recruitingThis study tests whether the drug interferon-α can prevent acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) from coming back in patients with a TP53 gene mutation who have already had a stem cell transplant. About 100 people aged 12-65 will receive interferon-α to s…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Healing harmonies: music and mindfulness may ease stem cell recovery
Symptom relief Not yet recruitingThis study tests an online program that combines mindfulness and music therapy to help people undergoing stem cell transplants for blood cancers feel better and recover faster. About 165 adults will participate, using a smartphone or computer to access guided sessions. The goal i…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC